Dr. Bobby Reddy, CMO at ImmunityBio, discusses the company's innovations in changing bladder cancer treatment standards, commercial readiness for Anktiva, physician engagement strategies, and global press outreach. The episode covers advancements in cancer therapy, regulatory team building, strategic drug production, and breakthroughs in cell-based therapies. It also explores challenges in biotech organization, collaborative efforts, and advice for aspiring CMOs.
